Literature DB >> 8832066

Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat.

A Rubino1, G Burnstock.   

Abstract

1. The vasoconstrictor effects of uridine 5'-triphosphate (UTP), uridine 5'-diphosphate (UDP), uridine 5'-monophosphate (UMP) and uridine were tested in the isolated pulmonary vascular bed of the rat. Comparison was made with the effects of adenine nucleotides, adenosine 5'-triphosphate (ATP), adenosine 5'-diphosphate (ADP), adenosine 5'-monophosphate (AMP) and with adenosine. The effect of P2x-purinoceptor desensitization and blockade was compared on the vascular responses to uracil and adenine nucleotides. 2. At doses ranging from 10(-8) to 10(-5) mol, UTP elicited dose-dependent vasoconstriction. UDP was equiactive to UTP, while UMP and uridine did not show vasomotor activity. Similarly, ATP showed dose-related vasoconstrictor activity. ADP was less potent than ATP in eliciting vasoconstriction, while AMP was active only at the higher doses tested and adenosine was ineffective. 3. Vasoconstriction was produced by ATP analogues with the following order of potency: alpha, beta-methylene ATP > ATP gamma S > beta, gamma-methylene ATP > 2-methylthio ATP > or = ATP. 4. Desensitization of P2x-purinoceptors by the selective agonist alpha, beta-methylene ATP did not modify the vasoconstrictor activity of UTP and UDP and only partially reduced vasoconstrictor responses to ATP, while it abolished vascular responses to alpha, beta-methylene ATP itself. 5. The antagonists of P2-purinoceptors, suramin and pyridoxalphosphate-6-azophenyl-2', 4'-disulphonic acid (PPADS), did not affect vascular responses to UTP and UDP, but reduced vasoconstriction evoked by beta, gamma-methylene ATP and ATP by about 70 and 30%, respectively. 6. This study demonstrates that uracil nucleotides, UTP and UDP, elicit vasoconstriction in the rat pulmonary vascular bed. In addition to confirming the presence of classical P2x-purinoceptors, these results also suggest the presence of a distinct purinoceptor subtype which mediates UTP- and ATP- evoked vasoconstriction in the rat pulmonary circulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832066      PMCID: PMC1909661          DOI: 10.1111/j.1476-5381.1996.tb15554.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.

Authors:  G Lambrecht; T Friebe; U Grimm; U Windscheif; E Bungardt; C Hildebrandt; H G Bäumert; G Spatz-Kümbel; E Mutschler
Journal:  Eur J Pharmacol       Date:  1992-07-07       Impact factor: 4.432

Review 2.  Purinoceptors: are there families of P2X and P2Y purinoceptors?

Authors:  M P Abbracchio; G Burnstock
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

Review 3.  G protein-coupled receptors for ATP and other nucleotides: a new receptor family.

Authors:  E A Barnard; G Burnstock; T E Webb
Journal:  Trends Pharmacol Sci       Date:  1994-03       Impact factor: 14.819

4.  Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder.

Authors:  S J Bailey; S M Hourani
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

5.  Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions mediated via P2x-purinoceptors.

Authors:  U Windscheif; V Ralevic; H G Bäumert; E Mutschler; G Lambrecht; G Burnstock
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

6.  Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown.

Authors:  A U Ziganshin; L E Ziganshina; B E King; G Burnstock
Journal:  Pflugers Arch       Date:  1995-01       Impact factor: 3.657

7.  Mechanisms of signal transduction for adenosine and ATP in pulmonary vascular bed.

Authors:  H L Lippton; Q Hao; T Hauth; A Hyman
Journal:  Am J Physiol       Date:  1992-03

8.  Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels.

Authors:  A U Ziganshin; C H Hoyle; G Lambrecht; E Mutschler; H G Bümert; G Burnstock
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

9.  P2Y purinoceptor and nucleotide receptor-induced relaxation of precontracted bovine aortic collateral artery rings: differential sensitivity to suramin and indomethacin.

Authors:  G F Wilkinson; K McKechnie; I A Dainty; M R Boarder
Journal:  J Pharmacol Exp Ther       Date:  1994-02       Impact factor: 4.030

10.  Pharmacological analysis of ecto-ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X-purinoceptor ligands.

Authors:  B E Crack; M W Beukers; K C McKechnie; A P Ijzerman; P Leff
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

View more
  14 in total

Review 1.  P2 receptor subtypes in the cardiovascular system.

Authors:  S P Kunapuli; J L Daniel
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

2.  Purinergic receptor stimulation induces calcium oscillations and smooth muscle contraction in small pulmonary veins.

Authors:  Mauricio Henriquez; Marcelo Fonseca; Jose F Perez-Zoghbi
Journal:  J Physiol       Date:  2018-05-23       Impact factor: 5.182

3.  The effect of purinergic P2 receptor blockade on skeletal muscle exercise hyperemia in miniature swine.

Authors:  S P Mortensen; R M McAllister; H T Yang; Y Hellsten; M H Laughlin
Journal:  Eur J Appl Physiol       Date:  2014-06-25       Impact factor: 3.078

4.  Regional variation in P2 receptor expression in the rat pulmonary arterial circulation.

Authors:  K Chootip; K F Ness; Y Wang; A M Gurney; C Kennedy
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

5.  Investigation of the functional expression of purine and pyrimidine receptors in porcine isolated pancreatic arteries.

Authors:  M Alsaqati; S L F Chan; V Ralevic
Journal:  Purinergic Signal       Date:  2013-12-06       Impact factor: 3.765

6.  Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats.

Authors:  Takayuki Matsumoto; Rita C Tostes; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-06       Impact factor: 4.733

7.  Evidence for the expression of multiple uracil nucleotide-stimulated P2 receptors coupled to smooth muscle contraction in porcine isolated arteries.

Authors:  S J Rayment; M L Latif; V Ralevic; S P H Alexander
Journal:  Br J Pharmacol       Date:  2007-01-29       Impact factor: 8.739

8.  Multiple regulation by external ATP of nifedipine-insensitive, high voltage-activated Ca(2+) current in guinea-pig mesenteric terminal arteriole.

Authors:  Hiromitsu Morita; Thapaliya Sharada; Tadashi Takewaki; Yushi Ito; Ryuji Inoue
Journal:  J Physiol       Date:  2002-03-15       Impact factor: 5.182

9.  Vasoconstriction of intrapulmonary arteries to P2-receptor nucleotides in normal and pulmonary hypertensive newborn piglets.

Authors:  M R McMillan; G Burnstock; S G Haworth
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

10.  Enhanced vasoconstrictor responses in renal and femoral arteries of the golden hamster during hibernation.

Authors:  P Karoon; G Knight; G Burnstock
Journal:  J Physiol       Date:  1998-11-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.